Stelexis Therapeutics
Initial Transaction Details
Transaction Date
November 2017
Purpose of Financing
Venture
Stage of Company
Seed/Startup
Structure of Financing
Debt and Equity
Stelexis is a New York‐based cancer therapeutics company, utilizing its proprietary platform to selectively target pre‐cancerous stem cells to discover and develop transformative therapies.
Website